跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 130 条关于
“Cas12a”
全部
130
临床试验
69
药物
28
机构
11
资讯
22
去年
Federal Circuit Remands CRISPR Patent Dispute to PTAB in Ongoing Editas Medicine Case
10天前
tBE Base Editing Therapy Achieves Durable Remission in Sickle Cell Disease and β-Thalassemia Across Diverse Genetic Backgrounds
4个月前
CRISPR-Cas Systems Emerge as Programmable Weapons Against MRSA Biofilms
去年
Base Therapeutics' NK Cell Therapy for Solid Tumors Receives FDA IND Approval
去年
Caribou Biosciences to Present Preclinical Data on CB-010 for Lupus at ACR Convergence 2024
10个月前
Caribou Biosciences to Present First Clinical Data from Dual Allogeneic CAR-T Programs in Lymphoma and Multiple Myeloma
去年
IDT Launches HDR Enhancer Protein to Boost CRISPR Gene Editing Efficiency in Therapeutic Applications
2年前
CRISPR Technology Shows Promise Across Diverse Clinical Applications
11个月前
CRISPRoff Epigenetic Editing Enables Durable Gene Silencing in CAR-T Cell Therapy
6天前
Editas Medicine Targets 2026 Patient Dosing for In Vivo CRISPR LDL Therapy EDIT-401
第 1 页,共 3 页
上一页
下一页